Senior Manager, HTA, Value and Evidence (HV&E), Oncology Pipeline

As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines. 

The Health Technology Assessment (HTA), Value & Evidence (HV&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions — to inform healthcare decision-making. 

ROLE SUMMARY 

The Senior Manager, HTA, Value & Evidence, Oncology Pipeline is responsible for development and execution of high-quality HV&E strategic efforts to support optimal access and reimbursement of Pfizer’s early-stage programs.  

This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of Pfizer’s early-stage programs.   

ROLE RESPONSIBILITIES  

• Supports the development of the access evidence generation strategy to support the value of Pfizer’s oncology pipeline assets, in close partnership with the cross-functional matrix team. 

• Supports the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the access evidence strategy to support global market access needs at launch and through lifecycle. 

• Supports the timely development of early launch deliverables including early global value dossiers, value and evidence strategy, integrated evidence plan, systematic literature reviews, early economic models, predictive analytics for value and evidence, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries. 

• Supports the design and execution of global Health Economics and Outcomes Research (HEOR) studies (e.g., network meta-analyses, real-world evidence) from concept through publication.   

• Supports the development of patient-reported outcomes strategy and incorporates humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements. 

• Provide strategic input into clinical trial designs (e.g. patient populations, comparators, endpoints) to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers. 

• Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs. 

• Partner with other cross functional colleagues to ensure strategic alignment and successful/timely execution of projects. 

• Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, p